ICD-10 Coding for Chemotherapy-Induced Neuropathy(G62.0, G62.0B, G62.0D)
Learn about the ICD-10 coding for chemotherapy-induced neuropathy, including code G62.0 and T45.1x5*, documentation requirements, and coding tips.
Complete code families applicable to Chemotherapy-Induced Neuropathy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G62.0 | Drug-induced polyneuropathy | Use when neuropathy is directly linked to chemotherapy agents. |
|
| T45.1x5* | Adverse effect of antineoplastic and immunosuppressive drugs | Use when documenting adverse effects of chemotherapy drugs. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutChemotherapy-Induced Neuropathy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Chemotherapy-Induced Neuropathy.
Failure to document the causal relationship
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation
Ensure all documentation includes causal language., Train staff on proper documentation techniques.
Using unspecified codes like G62.9
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with ICD-10 specificity requirements., Data Quality: Decreases accuracy of clinical data.
Mitigation
Ensure documentation specifies chemotherapy as the cause of neuropathy.
Documentation of causal relationship
Impact
Failure to document the link between chemotherapy and neuropathy.
Mitigation
Implement regular training and audits to ensure compliance.